This looks less ridiculous than the last metaanalysis on Ivermectin that was posted here. Still if you look at it there's some reason for caution. Not all of the included studies were RCTs, some were not blinded. If you look at the "Risk of Bias"-Table there are really only three studies that could qualify as high quality. I'm waiting for judgement from medical experts.
Unfortunately medical experts are not allowed to discuss this in public, so we’re left with back door meetings where Pharma execs will inevitably push outcomes that will be favorable for their bottom line. Who wants to invest billions of dollars into a new vaccine/anti-viral drug only to lose out on all that investment by Ivermectin which will not contribute a single cent to the Pharma execs year-end bonus?
I've heard and read quite a bunch of them discuss this in public in the past, they must've been unaware that this is illegal. Or maybe it just isn't.